2-(4-Chlorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

((Allyloxy)methyl)benzene, 95.0%, 5g

2-(3-Fluorophenyl)-2-[4-(4-fluorophenyl)piperazin-1-yl]acetic acid, 250mg

Morpholine, min. 99%, for synthesis, 100 ml, glass packaging

2-Methoxy-4-nitrobenzenesulfonyl chloride, 97.0%, 1g

7-FLUORO-1H-INDAZOLE-4-BORONIC ACID PINACOL ESTER, 95.0%, 100mg

(S)-2,2-Dimethylcyclopropanecarboxylic acid, 95.0%, 1g

2,6-Dimethoxypyrimidine-4-carboxylic acid methylester, 95.0%, 250mg

2-Methyloctanoic acid, 95.0%, 5g

(3,5-Bis(ethoxycarbonyl)phenyl)boronic acid, 97%, 1g

6-Bromo-[1,2,4]triazolo[4,3-b]pyridazine, 95.0%, 1g

2-[4-(8-Bromo-2-oxo-2,3-dihydroimidazo[4,5-c]quinolin-1-yl)phenyl]-2-methylpropionitrile, 98%, 100mg

3-Methylbenzofuran, 99.0%, 5g